Protein kinase A regulates ferroptosis by controlling GPX4 m6A modification through phosphorylation of ALKBH5
- PMID: 39901038
- PMCID: PMC12163066
- DOI: 10.1038/s41418-025-01453-3
Protein kinase A regulates ferroptosis by controlling GPX4 m6A modification through phosphorylation of ALKBH5
Abstract
GPX4-dependent ferroptosis has emerged as a therapeutic strategy for cancer treatment. Here, we demonstrated that protein kinase A (PKA) participates in the regulation of ferroptosis by controlling the m6A modification of GPX4 in an ALKBH5-dependent manner. Notably, we identified ALKBH5, an m6A demethylase, as a novel target of PKA, which drives phosphorylation-dependent degradation of ALKBH5 protein. Moreover, the deletion of ALKBH5 represses ferroptotic cell death by maintaining GPX4 m6A modification and stability. Thus, by regulating ALKBH5-dependent GPX4 stability, PKA acts as a key regulator of ferroptosis. Our study unveils the involvement of PKA in m6A modification, which could control GPX4-dependent ferroptosis and tumor progression.
© 2025. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval: All experiments with animals were approved by the Animal Care and Use Committee (IACUC), Sun Yat-sen University (Approve number: SYSU-IACUC-2024-000478) and performed according to the relevant ethical guidelines and regulations. This research did not involve human subject study.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources